Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2018, Article ID 8926786, 5 pages
https://doi.org/10.1155/2018/8926786
Research Article

Preoperative Low-Density Lipoprotein Apheresis for Preventing Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation

1Department of Surgery, Kidney Center, Tokyo Women’s Medical University, Tokyo, Japan
2Department of Medicine, Kidney Center, Tokyo Women’s Medical University, Tokyo, Japan

Correspondence should be addressed to Akihito Sannomiya; pj.en.ten-os.3br@nas

Received 15 December 2017; Revised 9 February 2018; Accepted 1 March 2018; Published 2 April 2018

Academic Editor: Gian Luigi Adani

Copyright © 2018 Akihito Sannomiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Vincenti and G. M. Ghiggeri, “New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis,” American Journal of Transplantation, vol. 5, no. 6, pp. 1179–1185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Artero, C. Biava, W. Amend, S. Tomlanovich, and F. Vincenti, “Recurrent focal glomerulosclerosis: natural history and response to therapy,” American Journal of Medicine, vol. 92, no. 4, pp. 375–383, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. M. B. Andresdottir, N. Ajubi, S. Croockewit, K. J. M. Assmann, L. B. Hibrands, and J. F. M. Wetzels, “Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange,” Nephrology Dialysis Transplantation , vol. 14, no. 11, pp. 2650–2656, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Pardon, V. Audard, S. Caillard et al., “Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients,” Nephrology Dialysis Transplantation , vol. 21, no. 4, pp. 1053–1059, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Y. Choy, T. M. Chan, and K. N. Lai, “Recurrent glomerulonephritis after kidney transplantation,” American Journal of Transplantation, vol. 6, no. 11, pp. 2535–2542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Shimizu, S. Higo, E. Fujita, A. Mii, and T. Kaneko, “Focal segmental glomerulosclerosis after renal transplantation,” Clinical Transplantation, vol. 25, no. 23, pp. 6–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. D. Strologo, I. Guzzo, C. Laurenzi et al., “Use of rituximab in focal glomerulosclerosis relapses after renal transplantation,” Transplantation, vol. 88, no. 3, pp. 417–420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Hickson, M. Gera, H. Amer et al., “Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence,” Transplantation, vol. 87, no. 8, pp. 1232–1239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Hristea, K. Hadaya, N. Marangon et al., “Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab,” Transplant International, vol. 20, no. 1, pp. 102–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Garrouste, G. Canaud, M. Büchler et al., “Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Clinical outcomes,” Transplantation, vol. 101, no. 3, pp. 649–656, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Yanagisawa, O. Otsubo, H. Nozaki et al., “Massive proteinuria after renal transplantation treated with LDL-apheresis,” Transplantation Proceedings, vol. 28, no. 3, pp. 1482-1483, 1996. View at Google Scholar · View at Scopus
  12. K. Masutani, R. Katafuchi, H. Ikeda et al., “Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases,” Clinical Transplantation, vol. 19, no. s14, pp. 59–64, 2005. View at Publisher · View at Google Scholar
  13. J. R. Diamond and M. J. Karnovsky, “Focal and segmental glomerulosclerosis: Analogies to atherosclerosis,” Kidney International, vol. 33, no. 5, pp. 917–924, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Muso, M. Yashiro, M. Matsushima et al., “Does LDL apheresis in steroid-resistant nephrotic syndrome affect prognosis?” Nephrol Dial Transplant, vol. 9, pp. 257–264, 1994. View at Google Scholar
  15. K. Yokoyama, S. Sakai, and T. Sigematsu, LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy. Clin Nephrol, vol. 50, 1-7, 50, 1998.
  16. V. J. Savin, R. Sharma, M. Sharma et al., “Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis,” The New England Journal of Medicine, vol. 334, no. 14, pp. 878–883, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Sakurai, E. Muso, H. Matushima, T. Ono, and S. Sasayama, “Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome,” Kidney International, vol. 56, pp. S210–S212, 1999. View at Publisher · View at Google Scholar
  18. T. Nakamura, Y. Kawagoe, H. Ogawa et al., “Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy,” American Journal of Kidney Diseases, vol. 45, no. 1, pp. 48–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Yokoyama, R. Hayashi, M. Satani, and A. Yamamoto, “Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 5, no. 6, pp. 613–622, 1985. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Tojo, S. Sakai, and T. Miyahara, “Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS),” The Japanese Journal Of Nephrology, vol. 30, no. 9, pp. 1153–1160, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Muso, M. Mune, Y. Fujii et al., “Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy,” Nephron, vol. 89, no. 4, pp. 408–415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Muso, M. Mune, N. Yorioka et al., “Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS),” Clinical Nephrology, vol. 67, no. 6, pp. 341–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Muso, M. Mune, T. Hirano et al., “A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome,” Nephron Extra, vol. 5, no. 2, pp. 58–66, 2015. View at Publisher · View at Google Scholar
  24. E. Muso, M. Mune, T. Hirano et al., “Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study,” Clinical and Experimental Nephrology, vol. 19, no. 3, pp. 379–386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Akioka, M. Okamoto, H. Ushigome et al., “Recurrence of focal glomerulosclerosis in post-renal transplant recipients: Report of two cases,” Transplantation Proceedings, vol. 36, no. 7, pp. 2167-2168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Sener, A. J. Bella, C. Nguan, P. P. W. Luke, and A. A. House, “Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function,” Clinical Transplantation, vol. 23, no. 1, pp. 96–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Ramos and C. C. Tisher, “Recurrent diseases in the kidney transplant,” American Journal of Kidney Diseases, vol. 24, no. 1, pp. 142–154, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Ideura, K. Hora, Y. Kaneko et al., “Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: A case report,” Transplantation Proceedings, vol. 32, no. 1, pp. 223–226, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Couser, “Recurrent glomerulonephritis in the renal allograft: an update of selected areas.,” Exp Clin Transplant, vol. 3, no. 1, pp. 283–288, 2005. View at Google Scholar · View at Scopus
  30. C. Ponticelli and R. J. Glassock, “Posttransplant recurrence of primary glomerulonephritis,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2363–2372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Iguchi, K. Tanabe, T. Yagisawa et al., “Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients,” Therapeutic Apheresis, vol. 1, no. 2, pp. 191–194, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Korbet, “Clinical picture and outcome of primary focal segmental glomerulosclerosis,” Nephrology Dialysis Transplantation , vol. 14, supplement 3, pp. 68–73, 1999. View at Google Scholar · View at Scopus